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Cell death pathways induced by DNA damage include apoptosis,
an active process of cell suicide, as well as mitotic cell death,
which results from the passage through mitosis of cells containing
unrepaired DNA breaks (Cohen-Jonathan et al, 1999). Ionizing
radiation, or chemicals, may produce many types of DNA damage
including single-strand breaks (SSB), double-strand breaks (DSB),
base damage, and DNA–DNA or DNA–protein crosslinks (Cole 
et al, 1980). A correlation between cell responses and the various
forms of DNA damage has not yet been fully described (Cohen-
Jonathan et al, 1999). Cole et al (1975) have presented evidence
that repairable SSB probably do not result in cell death, but DSB
are considered to be severe lethal events (Goodhead, 1989,
Tounekti et al, 1993). Nonetheless, the exact role of DNA breaks
in the triggering of cell death is far from being well established. 
Bleomycin (BLM) is a radiomimetic anticancer drug (in fact a
mixture of 11 compounds, the most abundant being bleomycin-A2
(BLM-A2)) that produces SSB and DSB in a catalytic way. On
average, each BLM molecule generates 8 to 10 DNA breaks
(Povirk et al, 1989); it is admitted that for every 6 SSB, 1 DSB is
created (Greenway and Beerman, 1986; Cullinan et al, 1991). We
previously demonstrated in cultured cells that moderate quantities
of BLM-generated DSB (between 500 and 50 000 DSB per cell)
induce a slow cell death reminiscent of the mitotic cell death
caused by ionizing radiations. However, larger numbers of DSB
(larger than 5 ´ 105, generated by the internalization of more than
3 ´ 105 BLM molecules per cell), provoke pseudoapoptosis, that
is, a fast cell death process that displays the morphological and
biochemical characteristics of apoptosis, directly caused by
bleomycin rather than by the relevant endonuclease (Tounekti 
et al, 1993). The internalization of large amounts of BLM is only
achievable after transient and reversible permeabilization of cells,
such as is obtained by cell electropermeabilization (EPN)
(Orlowski and Mir, 1993). BLM uptake is restricted by the fact
that BLM molecules do not diffuse through the plasma membrane
(Orlowski et al, 1988; Poddevin et al, 1991; Mir et al, 1996). Cell
EPN is an advantageous procedure by which the average number
of BLM molecules internalized by the cells may be controlled
since this number is proportional to the external BLM concentra-
tion at the time of EPN. Furthermore, cell EPN allows the
synchronization of the BLM effects just at the time the electric
pulses are delivered. The introduction of BLM by this method
provides a tool to study the cellular consequences of known
amounts of SSB and DSB generated at a given time. 
Deglyco-bleomycin-A2 (deglyco-BLM-A2) is a BLM-A2 deriv-
ative lacking the carbohydrate moiety (Oppenheimer et al, 1982).
It has been shown recently that, like all BLMs, deglyco-BLM-A2
has retained the ability to preferentially recognize the GC
sequences on DNA and to produce breaks at this position (Bailly
et al, 1995). Thus, deglyco-BLM-A2 and BLM-A2 share an iden-
tical mechanism of action at the DNA level. In this report though,
we show that, contrary to BLM, deglyco-BLM-A2 induces apop-
tosis in DC-3F cells and generates essentially SSB. Results
obtained in Chinese hamster fibroblasts strongly suggest that the
type of cell death depends on both the relative and the absolute
quantities of SSB and DSB generated per cell. 
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Summary Bleomycin is a cytotoxic antibiotic that generates DNA double-strand breaks (DSB) and DNA single-strand breaks (SSB). It 
is possible to introduce known quantities of bleomycin molecules into cells. Low amounts kill the cells by a slow process termed mitotic cell
death, while high amounts produce a fast process that has been termed pseudoapoptosis. We previously showed that these types of cell
death are a direct consequence of the DSB generated by bleomycin. Here, we use deglyco-bleomycin, a bleomycin derivative lacking the
carbohydrate moiety. Although this molecule performs the same nucleophilic attacks on DNA as bleomycin, we show that deglyco-bleomycin
is at least 100 times less toxic to Chinese hamster fibroblasts than bleomycin. In fact, deglyco-bleomycin treatment results in apoptosis
induction. In contrast, however, deglyco-bleomycin was found to generate almost exclusively SSB. Our results suggest that more than 
150 000 SSB per cell are required to trigger apoptosis in Chinese hamster fibroblasts and that SSB are 300 times less toxic than DSB. Taken
together with previous studies on bleomycin, our data demonstrates that cells can die by apoptosis, mitotic cell death, or pseudoapoptosis,
depending on the number of DNA breaks and on the ratio of SSB to DSB. © 2001 Cancer Research Campaign http://www.bjcancer.com
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MATERIALS AND METHODS 
Cells and chemicals 
Chinese hamster DC-3F fibroblasts were maintained in the previ-
ously described culture conditions (Orlowski et al, 1988). Cell
culture materials were obtained from Gibco Laboratories (Cergy-
Pontoise, France). Lyophilized BLM (Lab. Roger Bellon, Neuilly,
France) was dissolved in NaCl 0.9% at pH 7 and stored at –20˚C.
BLM-A2 was kindly provided by Nippon Kayaku (Tokyo, Japan).
Deglyco-BLM-A2 was prepared by BLM-A2 solvolysis using fluo-
rhydric acid (Kenani et al, 1988b). Deglyco-BLM purity (i.e. the
complete deglycosylation of the batch of BLM) was checked by
high-pressure liquid chromatography and by ion spray/mass spec-
trometry, according to Kenani et al (1988). DNase-free RNase and
proteinase K were purchased from Boehringer Mannheim
(Meylan, France) and all other products from Sigma Chemical Co
(La Verpillière, France) except when otherwise stated. 
Cell electropermeabilization procedures 
Cell electropermeabilization was performed using a square wave
pulse generator (PS-15 electropulsator, Jouan, Saint-Herblain,
France). After harvest by trypsinization of exponentially growing
cells and inactivation of trypsin by complete medium, cells were
washed 3 times in 0.5 mM Ca2+-supplemented serum-free S-MEM
(Gibco Lab). Cells were then resuspended in the same ice-cooled
medium at 2.2 ´ 107 cells ml–1. Aliquots of 67.5 ml of the cell
suspension were mixed with 7.5 ml of 10-fold concentrated drug
solutions. 50 ml of the mixture were immediately deposited
between two electrodes (2 mm apart) and subjected to the electric
treatment (8 pulses of 100 ms and 1250 V cm–1 delivered at a
frequency of 1 Hz). Then, cells were kept for 5 min at 24˚C,
diluted in complete culture medium and seeded or treated as
described below. 
Cytotoxicity determinations and cell staining with
trypan blue 
After EPN, cells were seeded in triplicate (500 cells per cell
culture dish 60 mm in diameter) and cultured for 5 days at 37˚C
for cloning efficiency assay. Colonies were counted and values
obtained were expressed as the percentage of the colonies obtained
with control cells treated in the absence of drug. The absolute
cloning efficiency of controls was 60 to 70%. To determine cell
morphology after the treatment, cells were trypsinized, harvested,
stained by the addition of an equal volume of trypan blue solution
(0.08% trypan blue and 0.005% p-hydroxybenzoic acid methyl,
sodium salt in phosphate buffered saline, PBS). Cells were then
observed in a haemocytometer under a phase-contrast light micro-
scope using 160x magnification. 
Treatments with apoptosis inhibitors 
One hour after cell EPN in the presence of deglyco-BLM-A2,
aurintricarboxylic acid (0.5–100 mM) or ZnCl2 (0.1–5 mM) or
CoCl2 (0.1–5 mM) were added to the culture medium and left until
cells were collected. After various incubation times at 37˚C, 
cells were processed to analyse DNA fragmentation as described
below. 
DNA damage analysis by alkaline elution 
Cells were labelled for 24 h with [2-14C]thymidine (0.02 mCi
ml–1). They were then electropermeabilized in the absence or pres-
ence of 0.1, 1 or 10 mM deglyco-BLM-A2 and incubated for
20 min at room temperature. DC-3F cells labelled for 24 h with
[3H]thymidine (0.2 mCi ml–1) were irradiated (2000 rad) on ice
using a 57Co source (Eldorado irradiator, A.E.C. Ltd, Canada).
Amounts of irradiated cells corresponding to 4.5 nCi of [3H]
thymidine-labelled DNA were added as internal standards to 2.5 ´
105 drug-treated [14C]-labelled cells. After 2 washings in ice-cold
PBS, cells were layered onto a polyvinyl filter (pore size, 0.5 mM,
Gelman Sciences, Ann Harbor, Michigan) and lysed with a solu-
tion of 2% SDS, 10 mM disodium EDTA (pH = 10) and 0.5 mg
ml–1 proteinase K. DNA was eluted from the filter with 2%
tetrapropylammonium hydroxide (Fluka, Mulhouse, France),
20 mM disodium EDTA and 0.1% SDS, pH 12.1, at a flow rate
of 0.2 ml min–1, with a fractional interval of 5 min. Quantification
of deglyco-BLM-A2-induced DNA breaks was performed by
measuring the fraction of [14C] DNA remaining on the filter when
75% of the [3H]-labelled internal standard DNA was still retained.
Irradiated [14C]-labelled cells were used to establish the calibration
curve giving the relationship between the effect of radiation and
the frequency of deglyco-BLM-A2-induced DNA breaks (radia-
tion-equivalent DNA damage). This curve was obtained by plot-
ting radiation dose (rads) versus [14C]DNA retention at 75%
retention of the [3H]DNA internal standard. 
Conventional DNA electrophoresis 
Cell DNA fragmentation was monitored by a gel electrophoresis
method adapted from Smith et al (1989). Briefly, after cell treat-
ment, samples of 106 cells were incubated at 50˚C for 1 h in 20 ml
of 10 mM EDTA, 50 mM Tris-HCl (pH 8.0) containing 0.5%
(w/v) sodium lauryl sarkosinate and 0.5 mg ml–1 proteinase K.
Then, 10 ml of 0.5 mg ml–1 DNase-free RNase was added to each
sample and incubation at 50˚C continued for 1 h. Samples were
heated to 70˚C, and 10 ml of 30% (w/v) glycerol, 0.25% (w/v)
bromophenol blue and 0.25% (w/v) xylene cyanol were added to
each sample before its loading into a dry well of a 1.5% (w/v)
agarose gel containing 0.1 mg ml–1 ethidium bromide. Electro-
phoresis was carried out at 5 V cm–1 in 2 mM EDTA, 89 mM Tris-
borate (pH 8.0) until the marker dye migrated at least 3–4 cm.
Analysis of the optical density of the bands was performed on
negatives of the gels, using a video camera and the BioProfil
program from Vilber Lourmat, France, for data analysis. 
Pulsed field DNA electrophoresis 
DC-3F cells were grown for 42 hours in the presence of [3H]-
thymidine (0.01 mCi ml–1) (Dupont de Nemours, Les Ulis, France)
in the usual culture medium. Labelled cells were electropermeabi-
lized as described above in the presence of various concentrations
of BLM or deglyco-BLM. After 5 min at 37˚C, cells were washed
three times at 4˚C in PBS without Ca++ and Mg++ and the final
pellet was suspended in 250 ml of NaCl (0.9%). 
Radiolabelled DC-3F cells were also exposed to various control
irradiation doses (10, 20 and 30 Gy) at 4˚C using an experimental
irradiator IBL 6000 (137Cs) (Cea, Saclay, France) yielding 
1.414 Gy min–1. The culture flasks were pre-cooled for 30 min and
kept on ice throughout the irradiation period. Immediately after1274 O Tounekti et al 
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irradiation, flasks were transferred to 37˚C for 5 min (like the elec-
tropermeabilized cells). Medium was then aspirated and replaced
with ice-cold PBS to stop DSB rejoining. Cell monolayers were
trypsinized on ice with a HEPES-buffered solution (pH = 7.8)
containing 0.25% trypsin and 0.04% EDTA. Cells were suspended
in cold growth medium containing 20% calf serum, centrifuged
and washed 3 times in ice-cold PBS before passing through a small
bore pipette to break up clumps. 
Experimental and control cell suspensions were mixed with an
equal volume of 1% low melting temperature agarose (Bethesda
Res Lab) kept at 40˚C to obtain a final concentration of 2 ´ 106
cells ml–1. Mixtures were immediately transferred to plug moulds
kept at 4˚C and were allowed to solidify for 1 hour. The solidified
plugs (7 mm ´ 4 mm  ´ 1 mm) were then taken out from the
moulds, placed at 4˚C for 1 h in a lysis solution (EDTA 0.5 M, 2%
Sarkosyl, 1 mg ml–1 proteinase K) to allow permeation of the lysis
agents, and incubated for 38 h at 50˚C. After lysis, plugs were
washed twice with TE for 30 min (10 mM Tris, 1 mM EDTA,
pH = 8) at 4˚C, incubated for 1 h with 0.1 mg ml–1 RNAse,
washed twice with TE and placed in 0.2 M EDTA at 4˚C. 
For pulsed-field gel electrophoresis, agarose gels (0.7%
Seakem, CTG, FMC, Rockland, ME, USA) were cast in 0.5 X
TBE (45 mM Tris Base, 45 mM boric acid, 1 mM EDTA).
Agarose plugs containing electropermeabilized, irradiated, or
control cells, as well as molecular size markers (Schizosaccharomyces
pombe, Bio-Rad, Ivry sur Seine, France) were placed into the
wells. Electrophoresis was then carried out in a PFGE CHEF DRII
apparatus (Bio-Rad) at 14˚C in 0.5 X TBE according to Foray et al
(1996). 
After electrophoresis, gels were stained in 0.1 mg ml–1 ethidium
bromide for 20 min and destained for 30 min in 0.5 3 TBE at 4˚C.
Following photography under UV light, lanes were separated from
wells for each sample and loaded into separate scintillation vials.
0.5 ml HCl 1 N were added to prevent rejellying. Agarose was
melted by heating, mixed with 7 ml of ReadyGel (Beckman) and
counted in a liquid scintillation counter. The fraction of activity
released (FAR) into the lane was determined according to the
following formula: 
Fraction of activity released = 100 ´
cpmlane
(1) cpmlane + cpmwell
Nuclei preparation 
Cells were washed twice with cold PBS and incubated for 5 min at
4˚C with 1 ml of lysis solution (20 mM Tris-HCl; 1 mM EDTA; 
10 mM pepstatin; 10 mM leupeptin; 1 mM alpha-dithiothreitol; 
0.4 mM phenyl-methyl-sulfonyl fluoride). Cells were then
collected with a rubber policeman and plates were rinsed with
another ml of lysis solution. After 25 min of incubation at 4˚C,
cells were homogenized using a Potter dounce A (30 strokes).
Nuclei were centrifuged (500 g, 15 min, 4˚C) and suspended in 
0.5 mM Ca2+-supplemented serum-free S-MEM at a density of 
2.2 ´ 107 nuclei ml–1. After nuclei incubation with Fe-BLM-A2 or
Fe-deglyco-BLM-A2 for various times, DNA fragmentation was
monitored as described above for cells. 
RESULTS 
Cytotoxicity determinations 
Deglyco-BLM-A2 displayed only a very low toxicity to intact,
non-electropermeabilized cells exposed for 1 hour to this product.
In fact, reduction to 50% of the cloning efficiency (EC50) was
never reached, even at the highest dose available (Figure 1A).
These results indicate that under the same experimental conditions
(Figure 1A), deglyco-BLM-A2 is more than 100 times less toxic
than BLM-A2. 
Cell EPN increases the toxicity of both BLM-A2 and deglyco-
BLM-A2 (Figure 1B). Nevertheless, deglyco-BLM-A2 is still about
100 times less toxic than BLM-A2 (Figure 1B). When electroper-
meabilized cells were exposed to cytotoxic concentrations of
deglyco-BLM-A2, no morphological signs of mitotic cell death
(Tounekti et al, 1993) were observed: in particular, no increase in
cell size or in nucleus size was detected before the cells became
trypan blue positive. On the contrary, cell shrinkage, blebbing at
the cell surface and condensation of chromatin were all observed
under light microscopy (data not shown). In other words, cells
treated with deglyco-BLM-A2 displayed the morphological char-
acteristics of apoptosis. 
Induction of apoptosis by deglyco-BLM-A2
Oligonucleosomal DNA ladder generation by deglyco-BLM-A2 in
electropermeabilized cells was investigated (Figure 2). It is known
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Figure 1 Determination of BLM-A2 and deglyco-BLM-A2 cytotoxicities on
intact cells (A) and on electropermeabilized cells (B). (sBLM-A2; (l)
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that the commercially available BLM generates DSB immediately
after its internalization by electropermeabilized cells, and that
these DSB mainly occur in the DNA linker between two consecu-
tive nucleosomes, resulting in the very rapid appearance of an
oligonucleosomal DNA ladder (Tounekti et al, 1993, 1995). The
same result was found with purified BLM-A2: the DNA ladder was
detectable even when incubation was stopped 5 min after delivery
of electric pulses, i.e. 5 min after the entrance of the drug inside
the cells (Figure 2, lane h). On the contrary, DNA fragmentation
was detected neither at 5 min nor at 1 h, nor even at 12 h after
deglyco-BLM-A2 treatment (Figure 2, lane b and c). Nevertheless,
the oligonucleosomal ladder was detectable 24 h after deglyco-
BLM-A2 internalization by cells exposed to 10 or 100 mM external
concentrations (Figure 2, lane d and e). Extensive DNA fragmen-
tation was detected 48 h after treatment with either of these 2
concentrations (Figure 2, lane f and g). In addition, a DNA ladder
was also detected 72 h after cell EPN in the presence of lower
deglyco-BLM-A2 concentrations (1 mM, data not shown). 
In additional experiments, DC-3F cells electropermeabilized in
the presence of deglyco-BLM-A2 were treated with known
inhibitors of the usual endonucleases involved in the apoptotic
processes (Peitsch et al, 1994). DNA fragmentation into oligo-
nucleosomal fragments was not inhibited by either the presence of
abcdefghi
Figure 2 Time course of deglyco-BLM-A2-induced DNA fragmentation in
DC-3F cells. Lane a, cells electropermeabilized in the absence of drug; lanes
b–g, DNA samples prepared 12 h (lanes b, c), 24 h (lanes d, e) or 48 h
(lanes f, g) after the electropermeabilization of the cells in the presence of
10 mM deglyco-BLM-A2 (lanes b, d, f) or 100 mM deglyco-BLM-A2 (lanes c, e,
g); lane h, DNA sample prepared 5 min after cell EPN in the presence of 10
mM BLM-A2; lane i, size marker (Phi X 174 DNA digested by HaeIII restriction
endonuclease) 
abcd f e
Figure 3 Inhibition of deglyco-BLM-A2-induced DNA fragmentation in 
DC-3F cells. Lane a, DNA samples prepared 24 h after cell EPN in the
presence of 100 mM deglyco-BLM-A2; lanes b-d, DNA samples prepared 
24 h after cell EPN in the presence of 100 mM deglyco-BLM-A2 followed by
the addition, 1 h after the electric pulses delivery, of (b) 1.5 mM CoCl2 or 
(c) 1.5 mM ZnCl2 or (d) 50 mM aurintricarboxylic acid; lane e, cells
electropermeabilized in the absence of deglyco-BLM-A2; lane f, size marker
(Phi X 174 DNA digested by HaeIII restriction endonuclease) 
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Figure 4 Analysis of DNA from DC-3F cells nuclei treated with BLM-A2 and
deglyco-BLM-A2. Lane a, size marker (Phi X 174 DNA digested by HaeIII
restriction endonuclease); lanes b–d, nuclei treated with 1 mM deglyco-BLM-
A2 for: (b) 2 h, (c) 1 h, (d) 5 min; lanes e–g, nuclei treated with 100 mM
deglyco-BLM-A2 for: (e) 2 h, (f) 1 h, (g) 5 min; lanes h–j, nuclei treated with
10 mM deglyco-BLM-A2 for: (h) 2 h, (i) 1 h, (j) 5 min; lanes k–m, nuclei treated
with 100 mM BLM-A2 for: (k) 2 h, (l) 15 min, (m) 5 min; lanes n–p, nuclei
treated with 10 mM BLM-A2 for: (n) 2 h, (o) 15 min, (p) 5 min; lane q, nuclei
incubated with 1 mM FeCl2 for 2 h; lane r, untreated nuclei 1276 O Tounekti et al 
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EDTA or EGTA (1–5 mM) or of diethylpyrocarbonate (1 nM–
10 mM) (data not shown). However, addition of 50 mM aurintri-
carboxylic acid (Figure 3, lane d) or of 1.5 mM ZnCl2 (Figure 3,
lane c) one hour after the EPN in the presence of deglyco-BLM-A2
resulted in the inhibition of DNA fragmentation. On the contrary,
under the same experimental conditions used for ZnCl2, CoCl2, a
potent inhibitor of BLM endonucleasic activity, was unable to
inhibit the deglyco-BLM-A2-induced DNA fragmentation (Figure 3,
lane b). These results indicate that deglyco-BLM-A2does not directly
generate the oligonucleosomal ladder: the ladder could result in fact
from the activation of specific cellular endonucleases. Therefore,
deglyco-BLM-A2 seems to induce a true apoptotic process. 
Effects of deglyco-BLM-A2 on isolated nuclei 
DNA fragmentation was also analysed in nuclei isolated from 
DC-3F cells. A 15 min treatment of isolated nuclei with BLM-A2
was sufficient for an oligonucleosomal ladder to appear (Figure 4,
lanes k–p), as expected for this apoptosis-mimetic drug (Tounekti
et al, 1993). This DNA fragmentation was as intense with 10 mM
as with 100 mM, in agreement with previous studies performed
with the commercial mixture of bleomycins (the similarity of the
results obtained with these 2 concentrations, 10 mM, and 100 mM,
was already discussed in Tounekti et al, 1993). In contrast, with
deglyco-BLM-A2, no oligonucleosomal ladder could be detected
during the first 2 hours of treatment, even at the highest concentra-
tion tested (1 mM) (Figure 4), nor even after longer periods (data
not shown). We conclude that the oligonucleosomal ladder
observed after deglyco-BLM-A2 treatment of electropermeabilized
cells most likely results from a cellular reaction triggered by the
DNA damages produced by the deglyco-BLM-A2 i.e. from a true
apoptosis requiring cytoplasmic factors. Indeed, the results from
isolated nuclei clearly show that deglyco-BLM-A2 is unable to
directly generate oligonucleosomal DNA fragmentation. 
DNA breaks generated in living cells by BLM-A2 or
deglyco-BLM-A2
DC-3F cells electropermeabilized in the presence of
various external concentrations of deglyco-BLM-A2 showed a
concentration-dependent accumulation of DNA breaks: 175, 744,
1031 and 1692 rad-equivalents for respectively 0, 0.1, 1 and 10
mM in comparison with control DC-3F cells not submitted to the
electric pulses. These results demonstrate that, once inside the
cells, deglyco-BLM-A2 actually generates DNA breaks. 
DNA of cells electropermeabilized in the presence of various
concentrations of BLM-A2 or of deglyco-BLM-A2 was analysed
by pulsed field gel electrophoresis. Control DC-3F cells exposed
to 10, 20 and 30 Gy showed a linear dose-dependent increase of
the fraction of activity released (FAR) (Figure 5). In the presence
of BLM concentrations as low as 10–9 M, a significant FAR
(approximately equivalent to an exposure to 15 Gy) could already
be detected (Figure 5). At 10–8 M it reached 30%, a much higher
percentage than that generated by exposure to 30 Gy. In the pres-
ence of 10–6 M deglyco-BLM-A2, a small FAR (approximately
equivalent to an exposure to 5 Gy) was detected. With 10 times
more deglyco-BLM-A2, FAR was slightly higher than that gener-
ated by exposure to 30 Gy, and with 10–4 M deglyco-BLM it was
slightly more important than with 10–8 M BLM-A2. Thus, the dose-
dependent increase in FAR with BLM-A2 is steeper and can be
detected at lower concentrations than the FAR increase observed
in the presence of deglyco-BLM-A2. 
DISCUSSION 
Deglyco-BLM-A2 is less toxic than BLM-A2
In spite of minor differences in their physicochemical properties
(Kenani et al, 1988a), deglyco-BLM-A2 and BLM-A2 share the
same mechanism of nucleophilic attack at the same DNA
sequences (Bailly et al, 1995). However, on intact cells, deglyco-
BLM-A2 is much less toxic than BLM-A2 Deglyco-BLM-A2
cytotoxicity was also determined in transiently and reversibly elec-
tropermeabilized cells, in which the plasma membrane does not
restrict hydrophilic molecule cytotoxicity. Under these conditions,
deglyco-BLM-A2 is still much less toxic than BLM-A2 (Figure 1).
Therefore, removal of the glycanic moiety from the bleomycin
molecule appears to have important biological consequences. 
Cell death pathways of cells treated with BLM-A2 or
deglyco-BLM-A2
Our results suggest that in the presence of deglyco-BLM-A2,
electropermeabilized cells follow a different cell death pathway
than with standard BLM. 
Indeed, a significant FAR is detected at the lowest toxic BLM
concentrations, and as we previously showed (Tounekti et al,
1993), cells treated at these low BLM concentrations are killed
through a mitotic cell death pathway resulting from the generation
of a few unrepaired DSB. We had also demonstrated that BLM is
an apoptosis-mimetic drug (Tounekti et al, 1993): at high intracel-
lular concentrations, BLM itself produces a large number of DSB,
mimics the endonucleases usually involved in classical apoptosis,
and leads to the generation of morphological characteristics of
apoptotic cells (Tounekti et al, 1995). Both cell death pathways
caused by BLM rely on the ability of BLM to generate DSB. 
In addition to causing morphological changes characteristic of
apoptosis, deglyco-BLM-A2 can also induce the appearance of an
oligonucleosomal ladder (Figure 2). However, in contrast to BLM
or to BLM-A2, the ladder can only be detected at least 24 hours
after deglyco-BLM-A2 internalization and, moreover, its
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generation is inhibited by the addition of aurintricarboxylic acid or
of zinc ions. These results suggest that a NUC-18-like endonu-
clease might be involved in the deglyco-BLM-A2-induced DNA
fragmentation (Peitsch et al, 1994). Moreover, the oligonucleo-
somal ladder could not be detected when isolated nuclei were
exposed to deglyco-BLM-A2 (Figure 4). The necessity for a cyto-
plasmic factor (like the apoptosis-related endonuclease itself, or a
kinase, protease or phosphatase able to activate an endonuclease
already present in the nucleus) strongly argues in favour of the
induction of an apoptotic process (White, 1996). Our observations
allow us to conclude that cells treated with deglyco-BLM-A2 die
through a true apoptotic process. 
DNA fragmentation generated by deglyco-BLM-A2
Possible variations in the endonucleasic activities of deglyco-
BLM and BLM were investigated as a potential explanation for
their differences in toxicity. Indeed, BLM cytotoxicity is related to
the generation of DSB (Tounekti et al, 1993, 1995) in spite of the
fact that BLM produces 6 SSB per DSB. Moreover, the link
between BLM lethal effects and the DSB generated by BLM at
low concentrations was confirmed in the results here reported.
Indeed, analysis of DNA fragmentation using pulsed field elec-
trophoresis (Figure 5) showed that at the lowest lethal BLM
concentration (10–9M), there was already a large FAR even as
soon as 5 min after drug delivery, in keeping with the direct
endonucleasic activity of BLM, and as demonstrated in previous
studies (Tounekti et al, 1993). 
Analysis of cell DNA recovered by alkaline elution revealed
that large quantities of DNA breaks occur in living cells within
minutes of internalization of 0.1 mM deglyco-BLM-A2 (a concen-
tration toxic for around 60% of the electropermeabilized cells).
This result confirms the hypothesis that DNA is the actual target of
deglyco-BLM-A2. It is very different, however, from the results
obtained using pulsed field electrophoresis: indeed, significant
amounts of FAR were detected only at much higher external
concentrations of deglyco-BLM-A2, concentrations 10 to 100
times higher than those already lethal. Thus, the DNA fragmenta-
tion revealed by the FAR cannot be directly responsible for the
lethal effects of the lowest toxic deglyco-BLM-A2 concentrations.
In other words, the DSB revealed by the FAR 5 minutes after treat-
ment should not be the cause of deglyco-BLM-A2 toxicity.
Moreover, no direct DSB were visualized in nuclei treated 
with deglyco-BLM-A2, i.e. under conditions where an excess of
deglyco-BLM-A2 has free access to its target for extended periods
of time (Figure 4). Thus, the DNA breaks generated by deglyco-
BLM-A2 at its lowest toxic concentrations (those shown by the
alkaline elution analysis) should essentially be SSB. 
Quantitative conclusions 
In this respect, it seems relevant to calculate the number of SSB
potentially generated in the electropermeabilized cells. To perform
these calculations, it is assumed that: 
(i) The absence of the glycanic part has no incidence on the rate
of internalization with respect to BLM. Were there to be a
modification, however, it would most likely be an increase in
internalization since the reduction in molecular weight due to
the absence of the glycanic moiety should accelerate crossing
of the electropermeabilized plasma membrane; in this case,
the resulting numbers would be minimal evaluations. 
(ii) In vivo, as in vitro, each BLM molecule produces 8 to 10
strand breaks (Povirk et al, 1989). 
(iii) Within the cell, the total nucleasic activity of deglyco-BLM-
A2 is roughly half of that of BLM-A2, as it is in vitro
(Oppenheimer et al, 1982; Kenani et al, 1988a). 
Under these assumptions and according to Poddevin et al (1991),
an external concentration of 10–4M deglyco-BLM should lead to
the internalization of an average of 3 ´ 107 molecules of deglyco-
BLM per DC-3F cell and should generate about 5 ´ 3 ´ 107 = 1.5 ´
108 SSB. Since a mammalian cell with 3 ´ 109 bp has approxi-
mately 1.5 ´ 107 nucleosomes, then it is reasonable to consider
that on average at least 10 SSB are made per nucleosome, i.e. on
the more accessible 20 to 30 bp of the linker region. This approxi-
mation would be valid if all the nucleosomal linker regions had the
same accessibility; this is, however, not the case. Thus on the short
stretches of DNA where deglyco-BLM-A2 makes SSB, the gener-
ation of 2 SSB at adjacent positions on the opposite DNA strands
is more than probable. These SSB coincidences can lead to the
generation of functional DSB that can explain FAR generation in
pulsed field electrophoresis. Indeed, it is reminded that DNA frag-
mentation by deglyco-BLM-A2 was detected at external concen-
trations as low as 10–7M when analysed by alkaline elution
(detection of SSB and DSB), whereas FAR was only detectable at
10–6M and essentially at 10–5M external concentrations when
using pulsed field electrophoresis (detection of DSB only). Thus,
(i) the results of these calculations strongly argue in favour of our
hypothesis that deglyco-BLM-A2 essentially generates SSB, and
(ii) the functional DSB occurring from SSB coincidences (when
very large numbers of SSB are generated) do not explain the lethal
effects of the deglyco-BLM-A2. 
Moreover, according to agreed estimations (Goodhead, 1989)
that 1 Gy (Cs137 g rays) results in 39 DSB and 1000 SSB per cell,
the 1.5 ´ 108 SSB per cell generated at 10-4M deglyco–BLM–A2
correspond to the number of SSB generated by an irradiation of 
1.5 ´ 105 Gy. According to Goodhead (1989), such an irradiation
is above the minimum required dose (105 Gy) for which coinci-
dence of single hits (i.e. coincidence of SSB) could actually result
in DSB generation. Therefore, this parallelism with the situation
described in the case of ionizing radiations reinforces our hypoth-
esis that deglyco-BLM-A2 generates almost exclusively SSB
unless the number of deglyco-BLM molecules is so high that DSB
are created by SSB coincidences. 
Intrinsic cytotoxicity of SSB and DSB 
Taking into account that deglyco-BLM-A2 and BLM-A2 generate
SSB and DSB by the same chemical reaction on DNA (Bailly et al,
1995), it seems interesting to compare the intrinsic toxic capacities
of SSB and DSB. At their lowest cytotoxic concentrations in
electropermeabilized cells, BLM (10–9M) generates 500 DSB
(Tounekti et al, 1993) and, deduced from the calculations reported
here, deglyco-BLM-A2 (10–7M) should generate 150 000 SSB.
Thus, DSB are intrinsically 300 times more cytotoxic than SSB.
This difference can be due either to the various efficiencies with
which SSB or DSB are repaired, or to the different cell death path-
ways resulting from the presence of SSB or DSB in the cell
genome. 
We have concluded that deglyco-BLM-A2 molecules can generate
essentially only SSB. Indeed, in theory, it cannot be excluded that1278 O Tounekti et al 
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deglyco-BLM-A2 molecules also generate a very small number of
DSB. In fact, with respect to the number of SSB generated, a minimal
value for the ratio of SSB to DSB can be estimated in the following
way. At 1 mM, deglyco-BLM-A2 generates 1 500 000 SSB. At this
concentration of deglyco-BLM-A2, the FAR is lower than that
obtained with 1 nM BLM, that corresponds to less than 500 DSB
(Tounekti et al, 1993). Thus, for deglyco-BLM-A2, the ratio of SSB
to DSB should be greater than 1 500 000/500, i.e. greater than 3000.
Since each individual molecule of deglyco-BLM-A2generates only 5
SSB, the probability that each molecule of deglyco-BLM-A2 gener-
ates a DSB is lower than 5/3000 = 0.0017. This value confirms the
notion that deglyco-BLM-A2 must likely generate essentially SSB. 
SSB induce apoptosis 
Since our previous results using bleomycin showed that DSB in
limited numbers do not induce apoptosis (Tounekti et al, 1993,
1995), and since deglyco-BLM-A2 molecules generate essentially
SSB, and furthermore, since cells treated with deglyco-BLM-A2
die through a true apoptotic process, it can be concluded that SSB
induce apoptosis. 
Until now, the role of SSB in apoptosis has been under debate.
There is a possibility that SSB precede the appearance of DSB in the
internucleosomal linker region (Tomei, 1991). However, SSB could
act as signals to induce apoptosis (Yoshida et al, 1993). Indeed, SSB
generated in camptothecin-treated HL-60 cells induced internucleo-
somal DNA cleavage, in spite of the fact that these SSB were rapidly
repaired after drug removal (Yoshida et al, 1993). However, in those
experiments, the existence of another signal could not be excluded
because (i) camptothecin does not interact directly with DNA but
with topoisomerase I, the DNA-binding protein actually responsible
for SSB, and (ii) topoisomerase I could have more than one role in
cell physiology. Our results strongly sustain the mechanism
proposed by Yoshida et al, since we show that the SSB directly
generated in the DNA by deglycoBLM-A2 molecules are in fact
signals leading to death through apoptosis. 
SSB, DSB and cell death 
In summary, under experimental conditions in which SSB and
DSB result from the same mechanism of DNA attack, one of three
different types of cell death can result, depending on the number
and kind of DNA breaks (Table 1). DSB are intrinsically very toxic
in themselves but are unable to induce apoptosis; SSB are much
less toxic and are in fact not directly toxic in themselves but
through induction of apoptosis. The difference in the intrinsic
cytotoxicities of SSB and DSB explains why BLM toxicity is actu-
ally related to the generation of DSB, even if BLM causes an
average of 6 SSB for one DSB (Grimwade and Beerman, 1986;
Cullinan et al, 1991). On the contrary, it may be suggested that
molecules that produce more than 500 SSB for one DSB could
induce apoptosis. 
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